Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 60.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 60.74 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,577.4 Cr -1.7% -4.8% 39.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹121,326.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 2% -0.8% 15.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.7%

-4.8%

39.2%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses